Cargando…

Value of the tuberculin skin testing and of an interferon-gamma release assay in haemodialysis patients after exposure to M. tuberculosis

BACKGROUND: Patients with end-stage renal disease (ESRD) and Mycobacterium tuberculosis infection pose a high risk of developing active TB disease. It is therefore important to detect latent TB infection (LTBI) to be able to offer treatment and prevent progression to TB disease. We assessed the valu...

Descripción completa

Detalles Bibliográficos
Autores principales: Anibarro, Luis, Trigo, Matilde, Feijoó, Diana, Ríos, Mónica, Palomares, Luisa, Pena, Alberto, Núñez, Marta, Villaverde, Carlos, González-Fernández, África
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447656/
https://www.ncbi.nlm.nih.gov/pubmed/22905901
http://dx.doi.org/10.1186/1471-2334-12-195
_version_ 1782244133187878912
author Anibarro, Luis
Trigo, Matilde
Feijoó, Diana
Ríos, Mónica
Palomares, Luisa
Pena, Alberto
Núñez, Marta
Villaverde, Carlos
González-Fernández, África
author_facet Anibarro, Luis
Trigo, Matilde
Feijoó, Diana
Ríos, Mónica
Palomares, Luisa
Pena, Alberto
Núñez, Marta
Villaverde, Carlos
González-Fernández, África
author_sort Anibarro, Luis
collection PubMed
description BACKGROUND: Patients with end-stage renal disease (ESRD) and Mycobacterium tuberculosis infection pose a high risk of developing active TB disease. It is therefore important to detect latent TB infection (LTBI) to be able to offer treatment and prevent progression to TB disease. We assessed the value of the tuberculin skin test (TST) and of an interferon-gamma release assay (Quantiferon®-TB Gold in-Tube, QFT) for diagnosing LTBI in ESRD patients, after prolonged exposure to a highly contagious TB case in a haemodialysis unit. As a high number of patients presented erythema without induration in the TST response, this type of reaction was also analysed. METHOD: The TST and QFT were simultaneously performed twelve weeks after the last possible exposure to a bacilliferous TB patient. If the first TST (TST-1) was negative, a second TST (TST-2) was performed 15 days later to detect a booster response. A comparison was made between the TST responses (including those cases with erythema without induration) and those for the QFT. The correlation with risk of infection and the concordance between tests were both analysed. RESULTS: A total of 52 patients fulfilled the inclusion criteria. Overall, 11 patients (21.2%) had a positive TST response: 3 for TST-1 and 8 for TST-2, and 18 patients (34.6%) showed a positive QFT response (p = 0.065). Erythema without induration was found in 3 patients at TST-1 and in a further 9 patients at TST-2. The three patients with erythema without induration in TST-1 had a positive TST-2 response. Concordance between TST and QFT was weak for TST-1 (κ = 0.21); it was moderate for overall TST (κ = 0.49); and it was strong if both induration and erythema (κ = 0.67) were considered. CONCLUSIONS: In patients with ESRD, erythema without induration in the TST response could potentially be an indicator of M. tuberculosis infection. The QFT shows better accuracy for LTBI diagnosis than the TST.
format Online
Article
Text
id pubmed-3447656
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34476562012-09-21 Value of the tuberculin skin testing and of an interferon-gamma release assay in haemodialysis patients after exposure to M. tuberculosis Anibarro, Luis Trigo, Matilde Feijoó, Diana Ríos, Mónica Palomares, Luisa Pena, Alberto Núñez, Marta Villaverde, Carlos González-Fernández, África BMC Infect Dis Research Article BACKGROUND: Patients with end-stage renal disease (ESRD) and Mycobacterium tuberculosis infection pose a high risk of developing active TB disease. It is therefore important to detect latent TB infection (LTBI) to be able to offer treatment and prevent progression to TB disease. We assessed the value of the tuberculin skin test (TST) and of an interferon-gamma release assay (Quantiferon®-TB Gold in-Tube, QFT) for diagnosing LTBI in ESRD patients, after prolonged exposure to a highly contagious TB case in a haemodialysis unit. As a high number of patients presented erythema without induration in the TST response, this type of reaction was also analysed. METHOD: The TST and QFT were simultaneously performed twelve weeks after the last possible exposure to a bacilliferous TB patient. If the first TST (TST-1) was negative, a second TST (TST-2) was performed 15 days later to detect a booster response. A comparison was made between the TST responses (including those cases with erythema without induration) and those for the QFT. The correlation with risk of infection and the concordance between tests were both analysed. RESULTS: A total of 52 patients fulfilled the inclusion criteria. Overall, 11 patients (21.2%) had a positive TST response: 3 for TST-1 and 8 for TST-2, and 18 patients (34.6%) showed a positive QFT response (p = 0.065). Erythema without induration was found in 3 patients at TST-1 and in a further 9 patients at TST-2. The three patients with erythema without induration in TST-1 had a positive TST-2 response. Concordance between TST and QFT was weak for TST-1 (κ = 0.21); it was moderate for overall TST (κ = 0.49); and it was strong if both induration and erythema (κ = 0.67) were considered. CONCLUSIONS: In patients with ESRD, erythema without induration in the TST response could potentially be an indicator of M. tuberculosis infection. The QFT shows better accuracy for LTBI diagnosis than the TST. BioMed Central 2012-08-20 /pmc/articles/PMC3447656/ /pubmed/22905901 http://dx.doi.org/10.1186/1471-2334-12-195 Text en Copyright ©2012 Anibarro et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Anibarro, Luis
Trigo, Matilde
Feijoó, Diana
Ríos, Mónica
Palomares, Luisa
Pena, Alberto
Núñez, Marta
Villaverde, Carlos
González-Fernández, África
Value of the tuberculin skin testing and of an interferon-gamma release assay in haemodialysis patients after exposure to M. tuberculosis
title Value of the tuberculin skin testing and of an interferon-gamma release assay in haemodialysis patients after exposure to M. tuberculosis
title_full Value of the tuberculin skin testing and of an interferon-gamma release assay in haemodialysis patients after exposure to M. tuberculosis
title_fullStr Value of the tuberculin skin testing and of an interferon-gamma release assay in haemodialysis patients after exposure to M. tuberculosis
title_full_unstemmed Value of the tuberculin skin testing and of an interferon-gamma release assay in haemodialysis patients after exposure to M. tuberculosis
title_short Value of the tuberculin skin testing and of an interferon-gamma release assay in haemodialysis patients after exposure to M. tuberculosis
title_sort value of the tuberculin skin testing and of an interferon-gamma release assay in haemodialysis patients after exposure to m. tuberculosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447656/
https://www.ncbi.nlm.nih.gov/pubmed/22905901
http://dx.doi.org/10.1186/1471-2334-12-195
work_keys_str_mv AT anibarroluis valueofthetuberculinskintestingandofaninterferongammareleaseassayinhaemodialysispatientsafterexposuretomtuberculosis
AT trigomatilde valueofthetuberculinskintestingandofaninterferongammareleaseassayinhaemodialysispatientsafterexposuretomtuberculosis
AT feijoodiana valueofthetuberculinskintestingandofaninterferongammareleaseassayinhaemodialysispatientsafterexposuretomtuberculosis
AT riosmonica valueofthetuberculinskintestingandofaninterferongammareleaseassayinhaemodialysispatientsafterexposuretomtuberculosis
AT palomaresluisa valueofthetuberculinskintestingandofaninterferongammareleaseassayinhaemodialysispatientsafterexposuretomtuberculosis
AT penaalberto valueofthetuberculinskintestingandofaninterferongammareleaseassayinhaemodialysispatientsafterexposuretomtuberculosis
AT nunezmarta valueofthetuberculinskintestingandofaninterferongammareleaseassayinhaemodialysispatientsafterexposuretomtuberculosis
AT villaverdecarlos valueofthetuberculinskintestingandofaninterferongammareleaseassayinhaemodialysispatientsafterexposuretomtuberculosis
AT gonzalezfernandezafrica valueofthetuberculinskintestingandofaninterferongammareleaseassayinhaemodialysispatientsafterexposuretomtuberculosis